Sign in
4

Changes in Ownership

ImmunityBio, Inc. Filed Acc 0001326110-23-000149

Chief Accounting Officer acquired 21,030 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
LAUER REGAN J Chief Accounting Officer 2023-12-15 Option exercise +21,030 74,932 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
LAUER REGAN J Chief Accounting Officer 2023-12-15 Option exercise · Restricted Stock Units −21,030 21,031 D: show line 2 in the form
Loading xslF345X05/wk-form4_1703022089.xml…